Ovum, Nov 2010, Pages: 29
, explains which trends will have the biggest impact, and analyzes the implications and opportunities of these developments for both pharmaceutical companies and providers of technologies and services
Datamonitor, Dec 2009, Pages: 17
In collaboration with analysts from Healthcare business unit, in this brief Ovum's PharmaceuticalTechnology team outlines the key changes in the pharma industry, explains which trends will have
Datamonitor, Jan 2008, Pages: 13
-2007 6
Figure 4: Number of layoffs announced by Big Pharma in 2006-2007 7
AstraZeneca PLC
Medicines Company, The
Pfizer Inc
2008 Trends to Watch: PharmaceuticalTechnology
Datamonitor, Dec 2008, Pages: 15
5: IT budget allocation for R&D and non-R&D processes in China and India 13
2009 Trends to Watch: PharmaceuticalTechnology
NeuroInsights, May 2011, Pages +: 500
of specific technological, demographic, regulatory and intellectual property trends 1: Executive Summary
The Brain Industry Revealed
Neuropharmaceuticals
Neurodevices
Neurodiagnostics
Investment Risks
NeuroInsights, May 2010
Drivers
Other Findings
A Brief History of the Science Behind Neurotechnology
2: Trends and Drivers
Converging Technology Drivers
Stem Cells and Neuroregeneration
Neuroimaging, Diagnostics and Disease
yStats.com GmbH & Co. KG, Aug 2010, Pages: 256
Key Findings
- Alternative fuel technologies, electricity derived from batteries or solar power, and hybrid vehicles are trends in the automotive industry.
- The Asian construction
yStats.com GmbH & Co. KG, Jan 2009, Pages: 88
Research Companies
6. Luxury
- Wealth and Luxury Trends for 2009
7. Apparel
- Top 4 Apparel Product-Trends for 2009
8. Electronics
- Consumer desire for “Green” Electronics on the rise
- Top 5 Technologies
Axis Research Mind, Feb 2011, Pages: 412
Global Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution
Axis Research Mind, Feb 2011, Pages: 333
BRICSS Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution
Decision Resources, Inc., Feb 2007, Pages: 42
PricewaterhouseCoopers Survey 6
Credibility of the Pharmaceutical Industry 6
Barrie G. James, Ph.D., Pharma Strategy Consulting 6
Positive Industry Dynamics 9
Inlicensing Technology and Late-Stage Products 9
Demand
Axis Research Mind, Feb 2011, Pages: 630
Global Market Watch: The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution
Arrowhead Publishers, Oct 2010, Pages: 385
arrival of novel analgesics is set to transform this market. GW Pharmaceuticals' Sativex (GW-1000), Allergan's Botox (botulinium toxin), Merck's Telecagepant (MK-0974), Novartis' Canakinumab (ACZ885
Axis Research Mind, Nov 2011, Pages: 629
Focus:
The ‘Biorepositories: Technologies & End-Users - A Global Market Watch, 2009-2015' reviews the latest trends in biobanking sector with a perceptive to disclose the near-future growth prospects
Axis Research Mind, Feb 2011, Pages: 599
and Europe, going ahead.
Report Focus:
- The report ‘Biochips - Products, Applications, Technologies And End-Use Markets Growth Analysis, 2009-2015’ reviews the latest biochips market trends with a perceptive
Decision Resources, Inc., June 2009, Pages: 20
pharmaceutical industry M&As took place between the beginning of 2007 and the end of the first quarter of 2009. What are the trends in deal size? What are the motivations for these deals?
- All eyes are on Pfizer
Axis Research Mind, Nov 2011, Pages: 615
with a CAGR of 7%.
Report Focus:
The ‘Biobanking: End-Users - A Global Market Watch, 2009-2015' reviews the latest trends in biobanking sector with a perceptive to disclose the near-future growth prospects
Decision Resources, Inc., May 2010, Pages: 25
Pharmaceutical companies can either take action that will ensure their position as knowledgeable and influential partners in drug prescribing or watch as others help doctors determine which drugs
Takeda Pacific, July 2007, Pages: 131
Alliances and M&As, 2005 to June-2007
Intellectual Property and Regulatory Approval
Intellectual Property
Regulatory Approval
Findings: Companies to Watch for Future R&D
RNAi Technology Companies on the Move
